Edition:
United States

EyeGate Pharmaceuticals Inc (EYEG.OQ)

EYEG.OQ on NASDAQ Stock Exchange Capital Market

1.20USD
14 Dec 2017
Change (% chg)

$-0.05 (-4.00%)
Prev Close
$1.25
Open
$1.24
Day's High
$1.24
Day's Low
$1.19
Volume
3,680
Avg. Vol
28,360
52-wk High
$3.89
52-wk Low
$0.90

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.07 -0.241
Jun '17 0.15 -0.276
Mar '17 0.18 -0.279
FY 2016 Dec '16 0.16 -0.376
Sep '16 0.27 -0.364
Jun '16 0.23 -0.457
Mar '16 0.00 -0.311
FY 2015 Dec '15 0.00 -0.351
Sep '15 0.00 -0.189
Jun '15 0.00 -0.242
Mar '15 0.00 -3.227
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-17 1 0.41 0.41 0.41 6.93
Earnings (per share)
Quarter Ending Dec-17 1 -0.24 -0.24 -0.24 -0.12
Quarter Ending Mar-18 1 -0.20 -0.20 -0.20 --
Year Ending Dec-17 1 -1.02 -1.02 -1.02 -0.88
Year Ending Dec-18 1 -0.66 -0.66 -0.66 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 32.07 35.50
P/E High - Last 5 Yrs. -- 40.71 45.22
P/E Low - Last 5 Yrs. -- 23.60 24.21
Beta -- 0.92 0.91
Price to Sales (TTM) 36.56 3.92 5.89
Price to Book (MRQ) 30.56 4.84 5.66
Price to Tangible Book (MRQ) -- 5.71 7.25
Price to Cash Flow (TTM) -- 22.98 24.38
% Owned Institutions 38.43 0.87 1.41

Dividends

  Company industry sector
Dividend Yield -- 1.56 1.49
Dividend Yield - 5 Year Avg -- 2.17 2.05
Dividend 5 Year Growth Rate -- 4.29 5.25
Payout Ratio(TTM) -- 47.46 46.15

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -72.77 6.31 6.81
Sales (TTM) vs TTM 1 Yr. Ago 11.59 5.12 5.59
Sales - 5 Yr. Growth Rate -- 9.98 10.23
EPS (MRQ) vs Qtr. 1 Yr. Ago 33.94 7.17 7.98
EPS (TTM) vs TTM 1 Yr. Ago 20.97 -- --
EPS - 5 Yr. Growth Rate -- 9.91 10.93
Capital Spending - 5 Yr. Growth Rate -- 15.13 15.14

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.49 2.55
Current Ratio (MRQ) 0.81 3.50 3.57
LT Debt to Equity (MRQ) 0.97 11.00 13.37
Total Debt to Equity (MRQ) 0.97 17.12 19.35
Interest Coverage (TTM) -1,163.53 49.79 44.50

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.26 54.91
Gross Margin - 5 Yr. Avg. -- 52.36 52.46
EBITD Margin (TTM) -2,477.49 -- --
EBITD - 5 Yr. Avg -- 18.39 15.51
Operating Margin (TTM) -2,480.68 14.76 6.68
Operating Margin - 5 Yr. Avg. -- 14.35 10.99
Pre-Tax Margin (TTM) -2,480.75 15.22 7.52
Pre-Tax Margin - 5 Yr. Avg. -- 14.66 11.40
Net Profit Margin (TTM) -2,480.75 11.39 3.74
Net Profit Margin - 5 Yr. Avg. -- 10.99 7.69
Effective Tax Rate (TTM) -- 24.37 24.27
Effective Tax Rate - 5 Yr. Avg. -- 23.47 24.07

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 945,352,167 851,754,569
Net Income/Employee (TTM) -- 110,567,097 99,535,212
Receivable Turnover (TTM) 1.68 5.90 6.13
Inventory Turnover (TTM) -- 2.73 3.55
Asset Turnover (TTM) 0.04 0.99 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -105.62 11.87 11.32
Return on Assets - 5 Yr. Avg. -- 12.86 12.28
Return on Investment (TTM) -422.60 15.07 14.44
Return on Investment - 5 Yr. Avg. -- 16.82 16.08
Return on Equity (TTM) -717.89 16.57 16.05
Return on Equity - 5 Yr. Avg. -- 17.83 17.28
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 43.96 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for EyeGate Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 38.43%
# of Holders: 19
Total Shares Held: 6,611,033
3 Mo. Net Change: -180,845
# New Positions: 5
# Closed Positions: 3
# Increased Positions: 8
# Reduced Positions: 5
# Net Buyers: 3
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.